The next era of transcatheter aortic valve replacement: a case illustrating the benefit of a fully re-positionable, re-sheathable, and retrievable prosthesis

Transcatheter aortic valve replacement (TAVR) is an accepted treatment modality for patients with symptomatic severe aortic stenosis (AS) who are deemed to be at high or extreme surgical risk [1,2]. Despite excellent results there remain modest yet significant complication rates [1,2].